As such, this particular pattern of expression may suggest that during IBD, a severe impairment of IL-33 signaling within the epithelial layer occurs, whereas IL-33/ST2 engagement may be enhanced in intestinal immune cells. This evidence concerns the gene IL1RL1 and inflammatory bowel disease.